Pharmacognosy
Medicines derived from plants or other natural sources are the study of the medicinal branch related to pharmacognosy. The American Society of Pharmacognosy defines pharmacognosy as the study of the physical, chemical, biochemical and biological properties of drugs, narcotics or potential drugs or narcotic substances of natural origin as well as drugs of natural origin of crude drugs. Although most pharmacognostic studies focus on plants and medicinal products derived from plants, other types of organisms are also considered to be of pharmacognostic interest, in particular various types of microbes and, recently, various marine organisms. Secondary metabolite is the study of molecules of natural products that the term defines as pharmacognosy because they are useful for their medicinal, ecological, taste or other properties.
• Primary and secondary metabolites
• Essential oils and pure isolates
• Medicinal and aromatic plant
Related Conference of Pharmacognosy
30th International Conference on Neuropharmacology and Neurochemistry
5th International Forum on Pharmacovigilance and Regulatory Affairs
Pharmacognosy Conference Speakers
Recommended Sessions
- Biomedical Diagnosis
- Biomedical model
- Biomedical Science
- Biomedical statistics
- Biomedicine
- Biopharmaceutical
- Computational Biomedicine
- Frontiers in Biomedicine
- Immunopharmacology
- Industrial pharmacy
- Medical devices
- Molecular biomedicine
- Nanotechnology
- Personalized medicine
- Pharmaceutical Technology
- Pharmacognosy
- Pharmacological sciences
- Pharmacotherapy
Related Journals
Are you interested in
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2027 (Netherlands)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2027 (Netherlands)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2027 (Netherlands)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2027 (Netherlands)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2027 (Netherlands)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2027 (Netherlands)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2027 (Netherlands)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2027 (Netherlands)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2027 (Netherlands)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2027 (Netherlands)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2027 (Netherlands)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)

